Cold Pain Therapy Market

Cold Pain Therapy Market: Global Opportunity Analysis and Industry Forecast, 2022-2029

PORTLAND, OREGON, UNITED STATE, August 23, 2022 /EINPresswire.com/ -- The cold pain therapy market is expected to grow in upcoming years due to factors such as rise in incidence of injuries in sports and increasing importance of exercise and gym activities. Increase in number of knee and hip surgeries around the world is one of the factors expected to boost the cold pain therapy market growth.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/9905

𝐆𝐞𝐭 𝐔𝐩 𝐓𝐨 𝟏𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭, 𝐓𝐢𝐥𝐥 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞 𝟐𝟎𝐭𝐡 𝐨𝐟 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟐

Key benefits of the report:

This study presents the analytical depiction of the global cold pain therapy market along with the current trends and future estimations to determine the investments.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
The current market is quantitatively analyzed from 2020 to 2027 to highlight the market growth scenario.
Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed cold pain therapy market analysis based on competitive intensity and how the competition will take shape in coming years.
Cold Pain Therapy comprises use of cold materials to relieve the pain. Cold pain therapy is also known as cryotherapy. It reduces the blood flow in a particular area of the body to decrease the inflammation and swelling around the joints. Cold pain therapy is used for relieving the local pain, myofascial pain and pain due to muscle spasm. Ice packs are mostly used as primary analgesics for relieving the pain. They are effective, inexpensive and a drugless method for relieving the pain from sprains, strains and swelling. Injuries which are caused due to sports activities and gym activities are major growth factors for driving the market growth.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on the cold pain therapy market.

Top Impacting factors:

Factors such as rise in incidence of sports injuries and increase in importance of gym activities has resulted in growth for the cold pain therapy market over the past years.
Growth in number of knee and hip surgeries around the world and need for safe pain management modalities as opposition for oral drug therapy is expected to drive the market growth for cold pain therapy market.
Increase in healthcare expenditure due to physical injuries caused due to lack of activity and obesity are some of the factors responsible for the market growth.
Initiatives of the government to support the cold pain therapy is expected to flourish the growth of the market.
However, factors such as lack of reimbursement, side effects, clinical evidence for medication and therapy and discomfort caused by the treatment is expected to hamper the growth of cold pain therapy market up to some extent over the forecast period.
New Product Launch / News:

In April 2019, Pacira BioSciences announced its acquisition with MyoScience, which is expected to advance the non-opioid pain management by adding the FDA-approved iovera system to the Pacira commercial offering. This will help healthcare providers and patients to fight the opioid crisis by offering innovative therapies to decrease or end the need for opioids
In 2018, Hisamitsu Pharmaceutical and Olympic and Paralympic Games,
Tokyo 2020 signed an agreement to be an official partner to provide external pain relief products during the 2020 Tokyo Olympic and Paralympic Games
In June 2018, Halyard Health, Inc. in Alpharetta announced an agreement for acquisition of Cool Systems, Inc., a provider of cold therapy and compression therapy systems. This will help in widening the orthopedic section and would provide innovative non-opioid therapies that decrease or eliminate the usage of opioids for surgical patients.

Key Segments Covered

By Product

OTC Products
Pharmaceuticals
Gels, Ointments and Creams
Sprays and Foams
Patches
Roll-ons
Roll-ons
Cooling Towels
Compresses
Wraps
Pads
Cold packs
By Application

Musculoskeletal Disorders
Sports Medicine
Post-Operative Therapy
Post-Trauma Therapy
By Therapy

Icepack Therapy
Chamber Therapy
Cryosurgery

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/9905

We also Offers Regional and Country Reports-

Japan Cold Pain Therapy Market
South Korea Cold Pain Therapy Market
Singapore Cold Pain Therapy Market
China Cold Pain Therapy Market
Indonesia Cold Pain Therapy Market
Australia Cold Pain Therapy Market
Taiwan Cold Pain Therapy Market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Nucleic Acid Labeling Market

Occlusion Devices Market

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.